Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Griffiths

Showing results (201-210 of 1,956) with videos related to

Pageof 196
Sort By:
Federation Proceedings|February 1, 1982
Experimental analysis of human cigarette smoking behaviorR R Griffiths, J E Henningfield
Pharmacology, Biochemistry, and Behavior|July 1, 1982
Differential control of puff duration and interpuff interval in cigarette smokersL D Chait, R R Griffiths
Clinical and Experimental Neurology|January 1, 1981
Acetylcholine receptor antibodies in the diagnosis and management of myasthenia gravisG A Nicholson, L R Griffiths
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
Drug discrimination analysis of partial agonists at the benzodiazepine site. I. Differential effects of U-78875 across training conditions in baboons and ratsN A Ator, R R Griffiths
Journal of the Royal Society of Medicine|August 1, 1995
Caffeine dependence: fact or fiction?E C Strain, R R Griffiths
Journal of Clinical Psychopharmacology|April 1, 1996
Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteersC R Rush, R R Griffiths
The Veterinary Record|May 28, 1977
Muscle disease in the chowI D Duncan, I R Griffiths
Headache|March 9, 2017
Genetics of Migraine: Insights into the Molecular Basis of Migraine DisordersHeidi G Sutherland, Lyn R Griffiths
NMR in Biomedicine|September 1, 1992
The contribution made by cell death and oxygenation to 31P MRS observations of tumour energy metabolismG M Tozer, J R Griffiths
Biofactors (Oxford, England)|August 5, 2003
Is glutathione an important neuroprotective effector molecule against amyloid beta toxicity?Vicki S Barber, Helen R Griffiths
Pageof 196

Showing results (201-210 of 1,956) with videos related to

Sort By:
Pageof 196
Federation Proceedings|February 1, 1982
Experimental analysis of human cigarette smoking behaviorR R Griffiths, J E Henningfield
Pharmacology, Biochemistry, and Behavior|July 1, 1982
Differential control of puff duration and interpuff interval in cigarette smokersL D Chait, R R Griffiths
Clinical and Experimental Neurology|January 1, 1981
Acetylcholine receptor antibodies in the diagnosis and management of myasthenia gravisG A Nicholson, L R Griffiths
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
Drug discrimination analysis of partial agonists at the benzodiazepine site. I. Differential effects of U-78875 across training conditions in baboons and ratsN A Ator, R R Griffiths
Journal of the Royal Society of Medicine|August 1, 1995
Caffeine dependence: fact or fiction?E C Strain, R R Griffiths
Journal of Clinical Psychopharmacology|April 1, 1996
Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteersC R Rush, R R Griffiths
The Veterinary Record|May 28, 1977
Muscle disease in the chowI D Duncan, I R Griffiths
Headache|March 9, 2017
Genetics of Migraine: Insights into the Molecular Basis of Migraine DisordersHeidi G Sutherland, Lyn R Griffiths
NMR in Biomedicine|September 1, 1992
The contribution made by cell death and oxygenation to 31P MRS observations of tumour energy metabolismG M Tozer, J R Griffiths
Biofactors (Oxford, England)|August 5, 2003
Is glutathione an important neuroprotective effector molecule against amyloid beta toxicity?Vicki S Barber, Helen R Griffiths
Pageof 196